...
机译:CHD1L表达增加了肿瘤进展,并作为预测生物标志物,可用于胰腺癌预后不良
Nanchang Univ Affiliated Hosp 2 Jiangxi Prov Key Lab Mol Med 1 Min Rd Nanchang 330006 Jiangxi;
Nanchang Univ Affiliated Hosp 2 Dept Hepatobiliary Surg 1 Min Rd Nanchang 330006 Jiangxi;
Nanchang Univ Affiliated Hosp 2 Dept Hepatobiliary Surg 1 Min Rd Nanchang 330006 Jiangxi;
Nanchang Univ Affiliated Hosp 2 Dept Clin Lab 1 Min Rd Nanchang 330006 Jiangxi Peoples R China;
Nanchang Univ Affiliated Hosp 2 Jiangxi Prov Key Lab Mol Med 1 Min Rd Nanchang 330006 Jiangxi;
Nanchang Univ Affiliated Hosp 2 Dept Clin Lab 1 Min Rd Nanchang 330006 Jiangxi Peoples R China;
Nanchang Univ Affiliated Hosp 2 Jiangxi Prov Key Lab Mol Med 1 Min Rd Nanchang 330006 Jiangxi;
Nanchang Univ Affiliated Hosp 2 Dept Clin Lab 1 Min Rd Nanchang 330006 Jiangxi Peoples R China;
Nanchang Univ Affiliated Hosp 2 Jiangxi Prov Key Lab Mol Med 1 Min Rd Nanchang 330006 Jiangxi;
Pancreatic cancer; Proliferation; CHD1L; Wnt/beta-catenin;
机译:CHD1L表达增加了肿瘤进展,并作为预测生物标志物,可用于胰腺癌预后不良
机译:长时间非编码RNA MEG3的表达降低是骨肉瘤进展和不良预后的潜在预测生物标志物
机译:长时间非编码RNA MEG3的表达降低是骨肉瘤进展和不良预后的潜在预测生物标志物
机译:环境对胰腺癌和脑癌分子生物标志物表达的影响
机译:在不良预后的癌症中,Cadherin-11介导的肿瘤进展和侵袭:可行的治疗靶点。
机译:长时间非编码RNA MEG3的表达降低是骨肉瘤进展和预后不良的潜在预测生物标志物
机译:肺癌1中肿瘤抑制因子的表达下调与肿瘤进展相关,是卵巢癌预后不良的生物标志物